sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation
<h4>Background</h4> We investigated the impact of the soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio to predict short-term risk of preeclampsia on clinical utility and healthcare resource utilisation using real-world data (RWD), and compared findings wit...
Main Authors: | Anne Dathan-Stumpf, Anna Rieger, Stefan Verlohren, Cyrill Wolf, Holger Stepan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870556/?tool=EBI |
Similar Items
-
sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01) -
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
by: Zeisler, H, et al.
Published: (2016) -
Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
by: Anca-Florina Tataru-Copos, et al.
Published: (2022-09-01) -
Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
by: Laura Ehrlich, et al.
Published: (2017-04-01) -
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
by: Dietmar Schlembach, et al.
Published: (2018-08-01)